Profile
James Scott Whitehurst formerly worked at Amgen, Inc., as Vice President-Finance & Operations from 2008 to 2016, XBiotech, Inc., as Chief Financial Officer, Elanco Tiergesundheit AG, as Chief Financial Officer from 2005 to 2006, and Keane Consulting, Inc., as Chief Financial Officer from 2005 to 2006.
Former positions of James Scott Whitehurst
| Companies | Position | End |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | 2016-03-31 |
| Keane Consulting, Inc. | Director of Finance/CFO | 2005-12-31 |
Elanco Tiergesundheit AG
 Elanco Tiergesundheit AG Pharmaceuticals: MajorHealth Technology Elanco Tiergesundheit AG manufactures animal vaccines. The firm provides pet health, livestock and Bioprotection products. The company's products include Atopica, Capstar, Deramaxx, Fortekor, Interceptor, Milbemax, Parc-tic and Sentinel. It is headquartered in Basel, Switzerland. | Director of Finance/CFO | 2005-12-31 |
| XBIOTECH INC. | Director of Finance/CFO | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| XBIOTECH INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Private companies | 2 |
|---|---|
| Keane Consulting, Inc. | |
Elanco Tiergesundheit AG
Elanco Tiergesundheit AG Pharmaceuticals: MajorHealth Technology Elanco Tiergesundheit AG manufactures animal vaccines. The firm provides pet health, livestock and Bioprotection products. The company's products include Atopica, Capstar, Deramaxx, Fortekor, Interceptor, Milbemax, Parc-tic and Sentinel. It is headquartered in Basel, Switzerland. | Health Technology |
- Stock Market
- Insiders
- James Scott Whitehurst
